HopeStage
Back to all studies
CompletedNCT01309373

Remission and Community Life in Schizophrenia Care

About this titleRead the official source — NCT01309373
Observational studyAges 18–65
The study in practice

Understand this study

Who was this study for?

This study was for people with schizophrenia. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateNovember 2010
Recruitment status
Completed
Enrollment listed in the registry
1,809
Sponsor
Janssen-Cilag, S.A.
Sponsor type
Unknown or unclear
Study type
Observational
Intervention type
OTHER
Study phase
Not clearly listed
Locations
Not clearly listed
Age range
From 18 Years to 65 Years
Official registry ID
NCT01309373
Official title
Show the full official title

Epidemiological Study to Assess the Psychosocial and Symptomatic Remission and Community Integration Status in Patients With Schizophrenia (REINTEGRA Study)

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Locations not listed

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Janssen-Cilag, S.A.

Who was this study for?

This study was for people with schizophrenia. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies